Top Pharmaceuticals companies in Poland by Debt to Equity Ratio
Poland
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
0.69
|
Dec. 31, 2023 | USD 10.82 | 1.26% |
|
Poland |
|
| 2 |
0.67
|
Dec. 31, 2023 | USD 206.43 | -1.32% |
|
Poland |
|
| 3 |
0.62
|
Dec. 31, 2023 | USD 1.21 | 2.55% |
|
Poland |
|
| 4 |
0.30
|
Dec. 31, 2023 | USD 2.29 | -0.51% |
|
Poland |
|
| 5 |
0.27
|
Dec. 31, 2023 | USD 3.70 | -4.04% |
|
Poland |
|
| 6 |
0.11
|
Dec. 31, 2023 | USD 0.91 | 1.01% |
|
Poland |
|
| 7 |
0.09
|
Dec. 31, 2023 | USD 9.62 | -0.82% |
|
Poland |
|
| 8 |
0.06
|
Dec. 31, 2023 | USD 5.97 | 1.29% |
|
Poland |
|
| 9 |
0.05
|
Dec. 31, 2023 | USD 12.56 | 1.66% |
|
Poland |
|
| 10 |
0.04
|
Dec. 31, 2023 | USD 0.26 | 3.38% |
|
Poland |
|
| 11 |
0.02
|
Dec. 31, 2023 | USD 21.34 | -0.01% |
|
Poland |
|
| 12 |
0.02
|
Dec. 31, 2023 | USD 1.87 | 0.85% |
|
Poland |
|
| 13 |
0.01
|
Dec. 31, 2023 | USD 1.16 | 2.64% |
|
Poland |
|
| 14 |
0.00
|
Dec. 31, 2023 | USD 6.89 | -1.14% |
|
Poland |
Frequently Asked Questions
-
Which Pharmaceuticals company in Poland has the highest Debt to Equity Ratio ?
The Pharmaceuticals company in Poland with the highest Debt to Equity Ratio is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at 0.69.
-
Which Pharmaceuticals company in Poland has the lowest Debt to Equity Ratio ?
The Pharmaceuticals company in Poland with the lowest Debt to Equity Ratio is Ryvu Therapeutics S.A. (Warsaw Stock Exchange: RVU.WA) at 0.00.
-
What are the top 10 Pharmaceuticals companies in Poland by Debt to Equity Ratio ?
The top 10 Pharmaceuticals companies in Poland by Debt to Equity Ratio are Selvita S.A., NEUCA S.A., Synthaverse S.A., Mabion S.A., BioMaxima S.A., BIOTON S.A., Poltreg S.A., Celon Pharma S.A., Captor Therapeutics Spolka Akcyjna and onesano S.A..
-
What are the bottom 10 Pharmaceuticals companies in Poland by Debt to Equity Ratio ?
The bottom 10 Pharmaceuticals companies in Poland by Debt to Equity Ratio are Ryvu Therapeutics S.A., Pharmena S.A., Medinice S.A., Bioceltix S.A., onesano S.A., Captor Therapeutics Spolka Akcyjna, Celon Pharma S.A., Poltreg S.A., BIOTON S.A. and BioMaxima S.A..
